Lina Mayorga

Lina Mayorga

Auto-generated profile, based on publicly available information

Lina Mayorga

Department of Oncology, University of Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
PDF file
MRMaria Rodriguez-Ruiz
Maria Rodriguez-Ruiz
IRInmaculada Rodríguez
Inmaculada Rodríguez
LMLina Mayorga
Lina Mayorga
TLTania Labiano
Tania Labiano
BBBenigno Barbes
Benigno Barbes
IMIGNACIO MELERO
IGNACIO MELERO
Radiotherapy can be synergistically combined with immunotherapy in mouse models, extending its efficacious effects outside of the irradiated field (abscopal effects). We previously reported that a regimen encompassing local radiotherapy in combination with anti-CD137 plus anti–PD-1 mAbs achieves potent abscopal effects against syngeneic transplanted murine tumors up to a certain tumor size. Knowing that TGFβ expression or activation increases in irradiated tissues, we tested whether TGFβ blockade may further enhance abscopal effects in conjunction with the anti–PD-1 plus anti-CD137 mAb combination. Indeed, TGFβ blockade with 1D11, a TGFβ-neutralizing mAb, markedly enhanced abscopal effects and overall treatment efficacy against subcutaneous tumors of either 4T1 breast cancer cells or large MC38 colorectal tumors. Increases in CD8 T cells infiltrating the nonirradiated lesion were documented upon combined treatment, which intensely expressed Granzyme-B as an indicator of cytotoxic effector capability. Interestingly, tumor tissue but not healthy tissue irradiation results in the presence of higher concentrations of TGFβ in the nonirradiated contralateral tumor that showed smad2/3 phosphorylation increases in infiltrating CD8 T cells. In conclusion, radiotherapy-induced TGFβ hampers abscopal efficacy even upon combination with a potent immunotherapy regimen. Therefore, TGFβ blockade in combination with radioimmunotherapy results in greater efficacy.


3 April 2023
Verified
Other
Open access
MRMaría E. Rodríguez-Ruiz
María E. Rodríguez-Ruiz
IRInmaculada Rodríguez
Inmaculada Rodríguez
LMLina Mayorga
Lina Mayorga
TLTania Labiano
Tania Labiano
BBBenigno Barbes
Benigno Barbes
IMIgnacio Melero
Ignacio Melero
Assessment of spontaneous lung metastases of 4T1 tumors in the indicated treatment groups corresponding to mice treated as in figure 2A. Metastases were detected and quantitated -number of lesions in the surface of the lung counted upon inspection under a magnification lens (left) and by real time RT-PCR for tumor specific gp70 RNA (right)-.


3 April 2023
Verified
Other
Open access
MRMaría E. Rodríguez-Ruiz
María E. Rodríguez-Ruiz
IRInmaculada Rodríguez
Inmaculada Rodríguez
LMLina Mayorga
Lina Mayorga
TLTania Labiano
Tania Labiano
BBBenigno Barbes
Benigno Barbes
IMIgnacio Melero
Ignacio Melero
Radiotherapy can be synergistically combined with immunotherapy in mouse models, extending its efficacious effects outside of the irradiated field (abscopal effects). We previously reported that a regimen encompassing local radiotherapy in combination with anti-CD137 plus anti–PD-1 mAbs achieves potent abscopal effects against syngeneic transplanted murine tumors up to a certain tumor size. Knowing that TGFβ expression or activation increases in irradiated tissues, we tested whether TGFβ blockade may further enhance abscopal effects in conjunction with the anti–PD-1 plus anti-CD137 mAb combination. Indeed, TGFβ blockade with 1D11, a TGFβ-neutralizing mAb, markedly enhanced abscopal effects and overall treatment efficacy against subcutaneous tumors of either 4T1 breast cancer cells or large MC38 colorectal tumors. Increases in CD8 T cells infiltrating the nonirradiated lesion were documented upon combined treatment, which intensely expressed Granzyme-B as an indicator of cytotoxic effector capability. Interestingly, tumor tissue but not healthy tissue irradiation results in the presence of higher concentrations of TGFβ in the nonirradiated contralateral tumor that showed smad2/3 phosphorylation increases in infiltrating CD8 T cells. In conclusion, radiotherapy-induced TGFβ hampers abscopal efficacy even upon combination with a potent immunotherapy regimen. Therefore, TGFβ blockade in combination with radioimmunotherapy results in greater efficacy.

3 April 2023
Verified
Other
Open access
MRMaría E. Rodríguez-Ruiz
María E. Rodríguez-Ruiz
IRInmaculada Rodríguez
Inmaculada Rodríguez
LMLina Mayorga
Lina Mayorga
TLTania Labiano
Tania Labiano
BBBenigno Barbes
Benigno Barbes
IMIgnacio Melero
Ignacio Melero
Myeloid cell content (density per gram) in cell suspension from non-irradiated tumors as those in figure 5. Macrophages are defined as CD45+ CD11b+ F4/80+; Dendritic cells (DC) as CD45+CD11b+CD11c+; myeloid-derived suppressor cells (MDSC) as CD45+CD11b+Ly6C+ or CD45+CD11b+Ly6G+ to estimate monocytic (M-MDSC) and granulocytic (G-MDSC) subtypes.